Dual Incretin Because both compounds reduce appetite and bodyweight, it is easy to assume they share a mechanism
Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers
In Systemic Lupus Erythematosus (SLE), it induces apoptosis in senescent bone marrow cells, while in Type 1 Diabetes (T1D), it may eliminate senescent pancreatic beta cells, reducing inflammation and preserving function
Key Benefits As per studies, may help in Uses and Indications BPC-157 peptide therapy may be recommended for individuals experiencing: Tendon and ligament injuries Muscle strains or joint damage Post-surgical recovery Inflammation or delayed healing Gastrointestinal irritation or ulcers Chronic overuse injuries from training or activity Safety and Side Effects BPC-157 is generally well tolerated when administered correctly
Current Pharmaceutical Design, 21(9), 11211125
These programmes are scientifically credible, but the products remain investigational for most proposed indications